Key Financial Data Of Reporting Company

C.I.MEDICAL CO.,LTD. - Filing #7273101

Concept As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
Key financial data of reporting company
Business results of reporting company
Net sales
47,068,000,000 JPY
67,493,000,000 JPY
45,628,000,000 JPY
43,072,000,000 JPY
42,891,000,000 JPY
41,454,000,000 JPY
40,050,000,000 JPY
41,205,000,000 JPY
37,393,000,000 JPY
36,349,000,000 JPY
Ordinary profit (loss)
1,699,000,000 JPY
2,621,000,000 JPY
3,295,000,000 JPY
2,961,000,000 JPY
3,889,000,000 JPY
3,848,000,000 JPY
4,595,000,000 JPY
4,605,000,000 JPY
4,773,000,000 JPY
4,449,000,000 JPY
Profit (loss)
1,167,000,000 JPY
1,948,000,000 JPY
2,582,000,000 JPY
2,926,000,000 JPY
2,714,000,000 JPY
Share capital
10,000,000 JPY
10,000,000 JPY
10,000,000 JPY
10,000,000 JPY
10,000,000 JPY
Total number of issued shares
50,000,000 xbrli:shares
10,000,000 xbrli:shares
10,000,000 xbrli:shares
10,000,000 xbrli:shares
10,000,000 xbrli:shares
Net assets
20,750,000,000 JPY
27,396,000,000 JPY
20,139,000,000 JPY
19,811,000,000 JPY
18,280,000,000 JPY
18,103,000,000 JPY
15,803,000,000 JPY
15,977,000,000 JPY
13,475,000,000 JPY
13,754,000,000 JPY
Total assets
43,184,000,000 JPY
63,166,000,000 JPY
41,506,000,000 JPY
40,819,000,000 JPY
30,186,000,000 JPY
29,536,000,000 JPY
19,545,000,000 JPY
19,915,000,000 JPY
18,347,000,000 JPY
18,897,000,000 JPY
Net assets per share
415.02
521.91
401.17
396.24
364.33
362.08
316.08
319.55
269.51
275.10
Dividend paid per share
12.5
25.2
25.2
28.2
58.4
Interim dividend paid per share
Basic earnings (loss) per share
23.34
125.34
41.65
38.97
50.43
51.65
58.53
56.42
58.42
54.30
Diluted earnings per share
Equity-to-asset ratio
0.481 xbrli:pure
0.413 xbrli:pure
0.483 xbrli:pure
0.485 xbrli:pure
0.603 xbrli:pure
0.613 xbrli:pure
0.809 xbrli:pure
0.802 xbrli:pure
0.734 xbrli:pure
0.728 xbrli:pure
Rate of return on equity
0.058 xbrli:pure
0.272 xbrli:pure
0.109 xbrli:pure
0.103 xbrli:pure
0.147 xbrli:pure
0.152 xbrli:pure
0.200 xbrli:pure
0.190 xbrli:pure
0.237 xbrli:pure
0.223 xbrli:pure
Price-earnings ratio
39.37 xbrli:pure
7.33 xbrli:pure
20.17 xbrli:pure
21.55 xbrli:pure
20.07 xbrli:pure
19.59 xbrli:pure
15.84 xbrli:pure
16.43 xbrli:pure
21.60 xbrli:pure
23.24 xbrli:pure
Payout ratio
0.537 xbrli:pure
0.129 xbrli:pure
0.098 xbrli:pure
0.096 xbrli:pure
0.215 xbrli:pure
Net cash provided by (used in) operating activities
6,153,000,000 JPY
-156,000,000 JPY
1,409,000,000 JPY
1,578,000,000 JPY
4,159,000,000 JPY
Net cash provided by (used in) investing activities
-4,105,000,000 JPY
-9,795,000,000 JPY
-10,049,000,000 JPY
-3,051,000,000 JPY
-764,000,000 JPY
Net cash provided by (used in) financing activities
376,000,000 JPY
9,825,000,000 JPY
6,710,000,000 JPY
-584,000,000 JPY
-150,000,000 JPY
Cash and cash equivalents
4,124,000,000 JPY
1,698,000,000 JPY
1,731,000,000 JPY
3,649,000,000 JPY
5,680,000,000 JPY
Number of employees
84 xbrli:pure
543 xbrli:pure
485 xbrli:pure
306 xbrli:pure
1,112 xbrli:pure
473 xbrli:pure
295 xbrli:pure
407 xbrli:pure
261 xbrli:pure
246 xbrli:pure
297 xbrli:pure
257 xbrli:pure
272 xbrli:pure
Average number of temporary employees
49 xbrli:pure
369 xbrli:pure
363 xbrli:pure
229 xbrli:pure
781 xbrli:pure
495 xbrli:pure
267 xbrli:pure
481 xbrli:pure
250 xbrli:pure
165 xbrli:pure
393 xbrli:pure
338 xbrli:pure
365 xbrli:pure
Total shareholder return
1.552 xbrli:pure
1.404 xbrli:pure
1.674 xbrli:pure
1.528 xbrli:pure
2.061 xbrli:pure
Total return on share price index
1.825 xbrli:pure
1.515 xbrli:pure
1.181 xbrli:pure
1.416 xbrli:pure
1.074 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.